Warning message
Missing Feeds plugin FeedsJSONPathParser. Please contact your site administrator.
For prostate cancer, there are both challenges and some early positive results from immunotherapy trials that remain intriguing. One of the key challenges is identifying those patients who will benefit from...
The ASCO Research Community Forum Annual Meeting is in September. As Chair of the Research Community Forum Council, I’m very excited about what’s in store for this year’s meeting and would like to encourage...
Drug companies play a key role in improving cancer care, but financial toxicity for patients continues to worsen. Eternal vigilance is the price of liberty from excessive drug costs, and we have an ethical...
Much of the news this week in prostate cancer will be generated by the ASCO Annual Meeting in Chicago. There are likely to be considerable news releases regarding precision medicine, and especially AR-V7, so I...
Pages